{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:01:53Z","timestamp":1761102113389},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/crd.0000000000000017","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T10:13:34Z","timestamp":1407233614000},"page":"210-216","source":"Crossref","is-referenced-by-count":11,"title":["Perspectives on Sudden Death Prevention in Hypertrophic Cardiomyopathy"],"prefix":"10.1097","volume":"22","author":[{"given":"Georgios K.","family":"Efthimiadis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zegkos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soultana","family":"Meditskou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Hadjimiltiades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210203","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0002-9149(78)90717-8","article-title":"Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation.","volume":"41","author":"Maron","year":"1978","journal-title":"Am J Cardiol"},{"key":"R2-3-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetrical hypertrophy of the heart in young adults.","volume":"20","author":"Teare","year":"1958","journal-title":"Br Heart J"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1996.03540030033028","article-title":"Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.","volume":"276","author":"Maron","year":"1996","journal-title":"JAMA"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0002-9149(81)90535-X","article-title":"Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.","volume":"47","author":"McKenna","year":"1981","journal-title":"Am J Cardiol"},{"key":"R6-3-20210203","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review.","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"R7-3-20210203","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"R8-3-20210203","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"key":"R9-3-20210203","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/hrt.53.4.412","article-title":"Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.","volume":"53","author":"McKenna","year":"1985","journal-title":"Br Heart J"},{"key":"R10-3-20210203","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/hrt.2006.099416","article-title":"Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.","volume":"93","author":"Melacini","year":"2007","journal-title":"Heart"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0735-1097(89)90302-1","article-title":"Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest.","volume":"13","author":"Cecchi","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(99)00056-X","article-title":"Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.","volume":"33","author":"Elliott","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R16-3-20210203","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/hrt.46.2.168","article-title":"Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.","volume":"46","author":"McKenna","year":"1981","journal-title":"Br Heart J"},{"key":"R17-3-20210203","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.65.7.1388","article-title":"Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.","volume":"65","author":"Maron","year":"1982","journal-title":"Circulation"},{"key":"R18-3-20210203","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0735-1097(90)92820-R","article-title":"Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy.","volume":"15","author":"Spirito","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"R19-3-20210203","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","article-title":"Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.","volume":"357","author":"Elliott","year":"2001","journal-title":"Lancet"},{"key":"R20-3-20210203","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0735-1097(02)02713-4","article-title":"Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.","volume":"41","author":"Olivotto","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R22-3-20210203","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1161\/01.CIR.85.6.2140","article-title":"Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test.","volume":"85","author":"Gilligan","year":"1992","journal-title":"Circulation"},{"key":"R24-3-20210203","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/0735-1097(90)90222-B","article-title":"Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants.","volume":"15","author":"Nienaber","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"R25-3-20210203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/hrt.47.2.177","article-title":"Syncope in hypertrophic cardiomyopathy.","volume":"47","author":"McKenna","year":"1982","journal-title":"Br Heart J"},{"key":"R26-3-20210203","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy.","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"key":"R27-3-20210203","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0002-9149(78)90870-6","article-title":"Malignant hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death.","volume":"41","author":"Maron","year":"1978","journal-title":"Am J Cardiol"},{"key":"R28-3-20210203","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R29-3-20210203","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"R30-3-20210203","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.amjcard.2010.06.077","article-title":"Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.","volume":"106","author":"Bos","year":"2010","journal-title":"Am J Cardiol"},{"key":"R31-3-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9149(81)90604-4","article-title":"Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.","volume":"48","author":"Maron","year":"1981","journal-title":"Am J Cardiol"},{"key":"R32-3-20210203","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.90.6.2743","article-title":"Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.","volume":"90","author":"Spirito","year":"1994","journal-title":"Circulation"},{"key":"R33-3-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/hrt.79.4.331","article-title":"Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.","volume":"79","author":"Cecchi","year":"1998","journal-title":"Heart"},{"key":"R34-3-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0735-1097(88)90181-7","article-title":"Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.","volume":"11","author":"McKenna","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"R35-3-20210203","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","article-title":"Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.","volume":"45","author":"Adabag","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R36-3-20210203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/hrt.32.2.219","article-title":"Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy.","volume":"32","author":"Edwards","year":"1970","journal-title":"Br Heart J"},{"key":"R37-3-20210203","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/01.CIR.82.6.1995","article-title":"Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.","volume":"82","author":"Frenneaux","year":"1990","journal-title":"Circulation"},{"key":"R38-3-20210203","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.CIR.84.2.686","article-title":"Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy.","volume":"84","author":"Counihan","year":"1991","journal-title":"Circulation"},{"key":"R39-3-20210203","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0735-1097(02)01950-2","article-title":"Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy.","volume":"40","author":"Ciampi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R40-3-20210203","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0735-1097(00)00818-4","article-title":"Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy.","volume":"36","author":"Okeie","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R41-3-20210203","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0002-9149(99)00063-6","article-title":"Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy.","volume":"83","author":"Kim","year":"1999","journal-title":"Am J Cardiol"},{"key":"R42-3-20210203","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.96.9.2987","article-title":"Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy.","volume":"96","author":"Sadoul","year":"1997","journal-title":"Circulation"},{"key":"R43-3-20210203","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0735-1097(99)00094-7","article-title":"Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy.","volume":"33","author":"Olivotto","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R44-3-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-7120-7-37","article-title":"Identification of high risk patients with hypertrophic cardiomyopathy in a northern Greek population.","volume":"7","author":"Efthimiadis","year":"2009","journal-title":"Cardiovasc Ultrasound"},{"key":"R45-3-20210203","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjcard.2007.09.101","article-title":"Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.","volume":"101","author":"Maron","year":"2008","journal-title":"Am J Cardiol"},{"key":"R46-3-20210203","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.amjcard.2006.05.063","article-title":"Prevalence of systolic impairment in an unselected regional population with hypertrophic cardiomyopathy.","volume":"98","author":"Efthimiadis","year":"2006","journal-title":"Am J Cardiol"},{"key":"R47-3-20210203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0002-9149(87)90998-2","article-title":"Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.","volume":"60","author":"Spirito","year":"1987","journal-title":"Am J Cardiol"},{"key":"R48-3-20210203","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000176917","article-title":"Apical segmental dysfunction in hypertrophic cardiomyopathy: progression into end-stage heart failure with sudden cardiac death.","volume":"86","author":"Ko","year":"1995","journal-title":"Cardiology"},{"key":"R49-3-20210203","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/hrt.2003.031161","article-title":"Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy.","volume":"91","author":"Thaman","year":"2005","journal-title":"Heart"},{"key":"R50-3-20210203","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2005.04.062","article-title":"Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.","volume":"46","author":"Biagini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R51-3-20210203","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"R52-3-20210203","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jacc.2005.05.087","article-title":"Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese.","volume":"46","author":"Kubo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R53-3-20210203","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-9149(97)00066-0","article-title":"Apoptosis as a possible cause of wall thinning in end-stage hypertrophic cardiomyopathy.","volume":"79","author":"Ino","year":"1997","journal-title":"Am J Cardiol"},{"key":"R54-3-20210203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heart.84.5.476","article-title":"Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.","volume":"84","author":"Varnava","year":"2000","journal-title":"Heart"},{"key":"R55-3-20210203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF02281865","article-title":"Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure.","volume":"97","author":"Ko","year":"1996","journal-title":"Hum Genet"},{"key":"R56-3-20210203","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/hrt.80.6.548","article-title":"Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.","volume":"80","author":"Arbustini","year":"1998","journal-title":"Heart"},{"key":"R57-3-20210203","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"R58-3-20210203","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1253\/circj.CJ-12-1561","article-title":"Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction.","volume":"77","author":"Efthimiadis","year":"2013","journal-title":"Circ J"},{"key":"R59-3-20210203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"R60-3-20210203","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjcard.2009.04.039","article-title":"Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.","volume":"104","author":"Efthimiadis","year":"2009","journal-title":"Am J Cardiol"},{"key":"R61-3-20210203","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.","volume":"332","author":"Watkins","year":"1995","journal-title":"N Engl J Med"},{"key":"R62-3-20210203","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the gene for human cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.","volume":"338","author":"Niimura","year":"1998","journal-title":"N Engl J Med"},{"key":"R63-3-20210203","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJM199204233261703","article-title":"Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.","volume":"326","author":"Watkins","year":"1992","journal-title":"N Engl J Med"},{"key":"R64-3-20210203","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0735-1097(02)01900-9","article-title":"Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy.","volume":"39","author":"Ackerman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R65-3-20210203","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1161\/01.CIR.0000042675.59901.14","article-title":"Prevalence and severity of benign mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.","volume":"106","author":"Van Driest","year":"2002","journal-title":"Circulation"},{"key":"R66-3-20210203","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0025-6196(11)60890-2","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy.","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R67-3-20210203","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1136\/jmg.2005.033886","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counseling.","volume":"42","author":"Ingles","year":"2005","journal-title":"J Med Genet"},{"key":"R68-3-20210203","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.","volume":"55","author":"Girolami","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R69-3-20210203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.hrthm.2011.08.009","article-title":"Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors.","volume":"9","author":"Maron","year":"2012","journal-title":"Heart Rhythm"},{"key":"R70-3-20210203","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","article-title":"Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.","volume":"40","author":"Choudhury","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R71-3-20210203","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2005.02.050","article-title":"Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy.","volume":"151","author":"Sorajja","year":"2006","journal-title":"Am Heart J"},{"key":"R72-3-20210203","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"R73-3-20210203","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.108.768119","article-title":"Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.","volume":"1","author":"Maron","year":"2008","journal-title":"Circ Heart Fail"},{"key":"R74-3-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","article-title":"Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.","volume":"3","author":"Rubinshtein","year":"2010","journal-title":"Circ Heart Fail"},{"key":"R75-3-20210203","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.","volume":"51","author":"Maron","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R76-3-20210203","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.amjcard.2012.05.035","article-title":"Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.","volume":"110","author":"Rowin","year":"2012","journal-title":"Am J Cardiol"},{"key":"R77-3-20210203","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacc.2006.08.055","article-title":"Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.","volume":"49","author":"Valeti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R78-3-20210203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2003.08.031","article-title":"Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging.","volume":"43","author":"van Dockum","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R79-3-20210203","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/01.CIR.0000165084.28065.01","article-title":"Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.","volume":"111","author":"van Dockum","year":"2005","journal-title":"Circulation"},{"key":"R80-3-20210203","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCHEARTFAILURE.109.862359","article-title":"Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.","volume":"3","author":"ten Cate","year":"2010","journal-title":"Circ Heart Fail"},{"key":"R82-3-20210203","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/heartjnl-2012-303339","article-title":"Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.","volume":"99","author":"Jensen","year":"2013","journal-title":"Heart"},{"key":"R83-3-20210203","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"R84-3-20210203","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"R85-3-20210203","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R86-3-20210203","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease.","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"key":"R87-3-20210203","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/CIRCULATIONAHA.106.613562","article-title":"The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death.","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"R88-3-20210203","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","article-title":"Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.","volume":"119","author":"Maron","year":"2009","journal-title":"Circulation"},{"key":"R89-3-20210203","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","article-title":"Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.","volume":"30","author":"Basso","year":"2009","journal-title":"Eur Heart J"},{"key":"R90-3-20210203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy 60 years of age.","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:49:03Z","timestamp":1620949743000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201409000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000017","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}